Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008555HBVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS10007636HBVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS30013278HIVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS30061554HIVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS30061555HIVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS30061556HIVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS20031922HPVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS20058819HPVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS20019109HPVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TVIS20033119HPVENSG00000145451.13protein_codingGLRA3NoNo8001O75311
Q9UPF3
TCGA Plot Options
Drug Information
GeneGLRA3
DrugBank IDDB01956
Drug NameTaurine
Target IDBE0000414
UniProt IDO75311
Regulation Typeagonist
PubMed IDs
Citations
GroupsApproved; Nutraceutical
Direct ClassificationOrganosulfonic acids
SMILESNCCS(O)(=O)=O
PathwaysCongenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; Taurine and Hypotaurine Metabolism; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX)
PharmGKBPA451590
ChEMBLCHEMBL239243